Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
about
Sporadic medullary thyroid carcinoma: clinical data from a university hospitalThe characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesisComprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil.A differential diagnosis of inherited endocrine tumors and their tumor counterpartsHypercalcitoninemia is not pathognomonic of medullary thyroid carcinomaRET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family.Retroperitoneoscopic adrenalectomy in pheochromocytoma.Multiple Endocrine Neoplasia Type 2B: Early Diagnosis by Multiple Mucosal Neuroma and Its DNA AnalysisRET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma.
P2860
Q33458398-B69F9D27-99E9-4A33-B5CD-C744CD09A1B3Q33587939-21425B78-3B8F-403E-8C1E-6AA81D5367ECQ33763898-F8ADE676-65C2-4500-A16F-D49ECAA7CAABQ33822855-4C128DF4-C3CB-4286-868F-02478C22AD1BQ34906650-8D3534CF-0EBA-4122-B451-D3EECD2ED412Q35895469-F5482E27-C1F7-4F4A-B836-305D6B8E0DE7Q35895509-7E6369F4-2E20-434A-B7F1-5320C18B6595Q37023603-6D5BF14B-947E-457D-855C-2178D3257C8DQ37261277-63219F56-B65C-4EB3-943F-6DC65918F225Q38010028-D44D3D75-5CA8-4E61-86EF-1C7FA4FBB11BQ38010035-3702343D-181D-4AAD-AB6C-ED04D01E7624Q41522198-4CFCC270-8E95-4611-AADD-3CBF0D6A0B11Q43993632-739269F9-FDB4-488B-915E-91CAFFE8D99C
P2860
Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@ast
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@en
type
label
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@ast
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@en
prefLabel
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@ast
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@en
P2093
P1433
P1476
Impact of RET proto-oncogene a ...... le endocrine neoplasia type 2.
@en
P2093
Delmar Muniz Lourenço
Marcelo Augusto Cortina Gonçalves dos Santos
Rodrigo de Almeida Toledo
Sergio Pereira de Almeida Toledo
P577
2006-02-01T00:00:00Z